James T. Glover, SVP, Operations and CFO at ANADYS PHARMACEUTICALS INC (ANDS), bought 1,800 shares at $2.00 ($4K) on 2007-11-16, disclosed to the SEC on 2007-11-19.
Open-market purchase of $4k ANDS by SVP, Operations and CFO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.05 | 200 | $410 | 11.1% |
| 2 | $2.10 | 1,000 | $2K | 56.6% |
| 3 | $2.00 | 600 | $1K | 32.3% |
| Total | $2.06 avg | 1,800 | $4K | 100% |
| Filing → |
| ANDS | BUY | 2007-11-13 | $11K | — | Filing → |
| ANDS | BUY | 2007-08-16 | $2K | — | Filing → |
| ANDS | BUY | 2007-03-02 | $14K | — | Filing → |